IP Library Assignment 054088/0046
Patent Assignment
Reel/Frame 054088/0046

Change of Name

Recorded: 2020-10-15 Pages: 4
Assignor
NEUROVIVE PHARMACEUTICAL AB
Executed: 2020-05-27
Assignee
ABLIVA AB
MEDICON VILLAGE, LUND, 223 81, SWEDEN
Covered Properties (8)
Novel Compound and Methods for its Production
Patent: 9,090,657 →
Application: 13/433,944 →
Publication: US 2012/0251581
Sanglifehrin Based Compounds
Patent: 9,119,853 →
Application: 13/575,212 →
Publication: US 2012/0295841
Sanglifehrin Derivatives and Methods for Their Production
Patent: 9,271,977 →
Application: 13/995,666 →
Publication: US 2014/0080837
Macrocyclic Compounds and Methods for Their Production
Patent: 9,139,613 →
Application: 14/006,341 →
Publication: US 2014/0038885
Novel Dosage Form
Patent: 9,504,728 →
Application: 14/348,859 →
Publication: US 2014/0234414
Novel Cell-Permeable Succinate Compounds
Application: 15/128,480 →
Publication: US 2017/0105961
Succinate Prodrugs for Use in the Treatment of Lactic Acidosis or Drug-Induced Side-Effects Due to Complex I-Related Impairment of Mitochondrial Oxidative Phosphorylation
Application: 15/128,496 →
Publication: US 2017/0100359
Use of Sanglifehrin Macrocyclic Analogues as Anticancer Compounds
Application: 16/349,757 →
Publication: US 2019/0328734
Related Assignments (10)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 29, 2012
From: MOSS, STEVEN JAMES; GREGORY, MATTHEW ALAN; WILKINSON, BARRIE
To: BIOTICA TECHNOLOGY LTD.
Reel/Frame 027955/0306 →
Assignment of Assignor's Interest Oct 16, 2013
From: MOSS, STEVEN JAMES; GREGORY, MATTHEW ALAN; WILKINSON, BARRIE
To: NEUROVIVE PHARMACEUTICAL AB
Reel/Frame 031412/0937 →
Assignment of Assignor's Interest Feb 3, 2014
From: BIOTICA TECHNOLOGY LIMITED (IN CREDITORS VOLUNTARY LIQUIDATION)
To: NEUROVIVE PHARMACEUTICAL AB
Reel/Frame 032120/0904 →
Assignment of Assignor's Interest Feb 3, 2014
From: MOSS, STEVEN JAMES; GREGORY, MATTHEW ALAN; WILKINSON, BARRIE; MARTIN, CHRISTINE JANET
To: BIOTICA TECHNOLOGY LIMITED (IN CREDITORS VOLUNTARY LIQUIDATION)
Reel/Frame 032120/0703 →
Assignment of Assignor's Interest Mar 11, 2014
From: BIOTICA TECHNOLOGY LIMITED (IN CREDITORS VOLUNTARY LIQUIDATION)
To: NEUROVIVE PHARMACEUTICAL AB
Reel/Frame 032404/0928 →
Assignment of Assignor's Interest Dec 21, 2015
From: MOSS, STEVEN JAMES; GREGORY, MATTHEW ALAN; WILKINSON, BARRIE; KENDREW, STEVEN GARY
To: NEUROVIVE PHARMACEUTICAL AB
Reel/Frame 037339/0836 →
Assignment of Assignor's Interest Jan 18, 2016
From: GREGORY, MATTHEW ALAN; MOSS, STEVEN JAMES
To: NEUROVIVE PHARMACEUTICAL AB
Reel/Frame 037508/0969 →
Assignment of Assignor's Interest Dec 6, 2016
From: ELMER, ESKIL; HANSSON, MAGNUS JOAKIM; EHINGER, KARL HENRIK JOHANNES; MOSS, STEVEN
To: NEUROVIVE PHARMACEUTICAL AB
Reel/Frame 040535/0897 →
Assignment of Assignor's Interest Dec 6, 2016
From: ELMER, ESKIL; HANSSON, MAGNUS JOAKIM; EHINGER, KARL HENRIK JOHANNES; PIEL, SARAH
To: NEUROVIVE PHARMACEUTICAL AB
Reel/Frame 040536/0256 →
Assignment of Assignor's Interest Jun 19, 2019
From: GRONBERG, ALVAR; HANSSON, MAGNUS JOAKIM; GREGORY, MATTHEW ALAN; MOSS, STEVEN JAMES
To: NEUROVIVE PHARMACEUTICAL AB
Reel/Frame 049522/0121 →